Background. Intradialytic cycling (IDC), delivered during haemodialysis (HD), has the potential to improve many health issues. This systematic review and meta-analysis examine the evidence on the effects of IDC on exercise capacity, quality of life (QoL), physical function and cardiovascular health. Methods. Twenty-four databases were searched alongside Internet and hand searching, and consultation with experts. Eligibility criteria were cluster randomized, randomized and quasi-randomized controlled trials (RCTs) of IDC versus usual care in prevalent adult HD patients. Primary outcome measures were exercise capacity (VO 2 peak and field tests) and QoL. Secondary measures were cardiac and physical function. Results. Thirteen RCTs were eligible. Eight provided data for use in meta-analyses, which indicated no significant change in VO 2 peak (mean difference, MD 1.19 mL/kg/min, 95% confidence interval À1.15 to 3.52, P ¼ 0.3), physical (mean change, MC 1.97, À8.27 to 12.22, P ¼ 0.7) or mental component (MC 3.37, À7.94 to 14.68, P ¼ 0.6) summary scores of the Medical Outcomes Short Form 36, pulse wave velocity (MD À0.57 m/s, À1.55 to 0.41, P ¼ 0.4), systolic (MD À2.28 mmHg, À14.46 to 9.90, P ¼ 0.7) or diastolic blood pressure (MD 2.25 mmHg, À3.01 to 7.50, P ¼ 0.4) following IDC. IDC, however, leads to an improvement in performance on the 6-min walk test (MD 87.84 m,.09, P ¼ 0.0004). All included studies were considered to have high risk of bias. Conclusions. There is insufficient evidence demonstrating whether cycling exercise during HD improves patient
I N T R O D U C T I O N
The incidence and prevalence of end-stage renal disease (ESRD) requiring dialysis is increasing, with the majority of patients undertaking haemodialysis (HD) [1] . These patients have significantly increased morbidity and mortality, with cardiovascular disease as the leading cause of death [2] . Skeletal muscle catabolism, malnutrition, anaemia, uraemia, chronic inflammation, comorbidities and physical inactivity, together with 'enforced' sedentary time during HD [3] contribute to a reduction in exercise and functional capacity that are associated with disability [4] , increased healthcare utilization [5] and reduced quality of life (QoL) [6] .
Exercise interventions have the potential to target several of these issues. The majority of previous reviews have examined the effects of exercise in general within the HD population [7] [8] [9] [10] . 'Intradialytic exercise' (an umbrella term covering a range of heterogeneous exercise interventions delivered during HD) is, however, often advocated due to greater adherence rates [11] . Recent systematic reviews indicate that intradialytic exercise can significantly improve exercise capacity [12] , physical QoL [12, 13] and blood pressure (BP) [13] , but the interventions used include a range of different components. In choosing to review methods of exercise delivery rather than the specific type of intervention undertaken, clinicians and policymakers lack clear information on which specific modes of intradialytic exercise are most beneficial, hampering the translation of research evidence into practice.
As intradialytic exercise delivered solely by means of a cycle ergometer (intradialytic cycling, IDC) is most commonly done within clinical practice [14] , the aim of this review is to provide an up-to date synthesis of available evidence comparing the effects of IDC versus usual care on exercise capacity, QoL, physical function and cardiovascular health in HD patients.
M A T E R I A L S A N D M E T H O D S
Protocol registration and eligibility criteria A pre-specified protocol was published on PROSPERO (www.crd.york.ac.uk/PROSPERO identifier CRD42016030006 , date last accessed)). Eligibility criteria included cluster randomized, randomized and quasi-randomized controlled trials (RCTs) of prevalent HD patients. Trials in which it was possible to elucidate the direct effects of IDC training were included; studies of acute responses to a single bout of IDC were excluded. Control groups were defined as those who received usual care HD, for 4 h thrice weekly, not receiving any form of exercise intervention, counselling or education. Primary outcome measures included: exercise capacity measured by VO 2 peak; treadmill or field tests [e.g. 6 
Study identification
To identify existing relevant trials and systematic reviews, the pre-specified databases, in addition to the NIHR (National Institute of Health Research) Centre for Reviews and Dissemination Database, SciELO (Scientific Electronic Library Online), OAIster (Open Archives Initiative), SCOPUS, BASE (Bielefeld Academic Search Engine) and Open Grey, were searched from inception to March 2017, supplemented with Internet searching until 4 July 2017, hand searching reference lists and consultation with experts. No restrictions were placed upon publication, language status or year of publication. Search terms were adapted to database requirements and the full search strategy for the MEDLINE database is shown in Supplementary data, Item S1.
Study selection, data extraction and risk of bias assessment
Search results were managed using Refworks (ProQuest, Ann Arbour, MI, USA). Duplicate citations were removed, and the remaining citations screened against eligibility criteria. Titles and abstracts deemed not to meet these criteria were excluded. For the remaining citations, full-text articles were assessed for eligibility by H.M.L.Y., D.S.M. and M.P.M.G.B.. Disagreements were resolved by discussion with recourse to a fourth reviewer if needed.
Data from eligible studies were extracted by one reviewer and checked by another, using a template based upon the Cochrane collaboration tool. Information relating to study design, population, intervention, usual care control, outcomes and adverse events were recorded. Where multiple reports originated from a single study, comparison of the key characteristics was done using tables and were only included, as a single study, if they reported relevant outcomes to avoid overstating results. Where missing data were encountered, original authors were contacted.
Reviewers independently assessed study quality according to the Cochrane Risk of Bias assessment tool. Risk of bias for RCTs was assessed as high, low or unclear across five domains [15] . The overall risk of bias was determined using the following criteria: (i) low risk of bias (all criteria graded adequate), (ii) moderate risk of bias (one criterion graded inadequate or two unclear) and (iii) high risk of bias (more than one criterion graded inadequate or more than two unclear).
Statistical analysis
Descriptive statistics were used to study characteristics of included studies. Where means and standard deviation (SD) were neither reported nor available from study authors [16, 17] , they were estimated from medians and interquartile ranges [18] or SD was calculated from standard error [19, 20] . Only data from the first period within crossover trials were used to reduce the potential influence of carry-over.
All outcomes were treated as continuous data and interpreted as mean differences. Analysis was primarily based upon final values. In circumstances of baseline imbalances between groups, analysis was based on changes from baseline [15] . Statistical heterogeneity was assessed with the I 2 test, which describes the percentage of variation across studies above that attributed to chance [21] . Heterogeneity was considered unimportant for I 2 -values up to 40% [15] . RevMan 5.3 software was used to undertake meta-analyses. Data pertaining to similar outcome measures were pooled (with participant as the unit of analysis) in a meta-analysis, using a random effects model, which assumes that the observed estimates of treatment effect vary across studies due to within-and between-study variance [22, 23] . Pre-planned subgroup and sensitivity were not possible due to the limited number of studies available for meta-analysis and all studies being classified as high risk of bias, respectively.
R E S U L T S
Search results and study characteristics Supplementary data, Item S3 provides a summary of the characteristics of included trials. Included trials were published between 1995 and 2016 in English. Twelve were individually randomized [17, 19, 20, [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] , and one cluster randomized [16] . Twelve used a parallel group design and one a crossover design [17] . All trials measured outcomes at baseline and at the end of the intervention [16, 17, 19, 20, [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] ; of these, two also measured outcomes at an interim time point [27, 33] . Only one study included longer follow-up, 1 month post-intervention [28] . In total, 369 patients were randomized to receive IDC (n ¼ 190) or usual care (n ¼ 179) with sample sizes ranging from 18 to 49.
Characteristics of IDC
Full reporting of the IDC intervention was lacking in several studies, and the characteristics of IDC interventions ranged widely between studies. Five studies did not provide information regarding the mode of IDC training used [17, 24, 26, 29, 30, 32] , four provided continuous training [19, 20, 27, 31] , two interval training [16, 33] and two a combination [25, 28] . Mean duration of exercise training was 14 weeks (range . In all but one study, where patients exercised twice a week [16] , they were encouraged to exercise at each HD session. The mean duration of each planned bout of training was 31 min (range 20-45) and a majority required patients to exercise at a moderate intensity [19, 20, 24-27, 29, 33] . Actual levels of concordance were difficult to ascertain, as only four studies reported adherence level [17, 25, 26, 28, 29] and only three summarized the amount of exercise achieved [17, 26, 29, 33] . Where reported, mean adherence rates were 81%. Only five trials reported on adverse events [16, 17, [25] [26] [27] 29] , of which four reported no events [16, 17, 25, 27] and one no 'significant complications' [26, 29] . Exercise training was provided by researchers in three studies [20, 25, 27] , 'physical activity experts' in one study [19] and HD staff in another [17] . One study reported the intervention being provided by medical and nursing staff, but it was unclear whether these were attached to the trial or the HD unit [31] . Seven studies did not report who was delivering the intervention [16, 24, 26, 28-30, 32, 33] .
Risk of bias assessment
Risk of bias summaries for all included studies are provided in Table 1 . All studies were rated as high risk of bias, primarily due to insufficient reporting. Only one study provided the information required to assess bias across all domains and was judged to be of high risk in all [25] .
Effect of IDC
Exercise capacity. Nine studies reported outcomes related to exercise capacity. Five studies measured VO 2 peak [16, 19, [26] [27] [28] ; however, it was not possible to include VO 2 data from the cluster RCT in meta-analyses due to inadequate reporting [16] . One study used maximum work capacity, measured in watts [33] . Three studies used the 6MWT [19, 25, 31] and one the ISWT [20] , both field tests of exercise capacity. Four studies including 85 participants provided VO 2 peak data appropriate for meta-analysis. A non-significant improvement of 1.19 ml/kg/ min [95% confidence interval (CI) À1.15 to 3.52, P ¼ 0.3, Figure 2A ] was observed immediately following IDC compared with usual care [19, [26] [27] [28] . Statistical heterogeneity was low I 2 ¼ 10%. The study that reported maximal work capacity also reported no significant difference between IDC and usual care [33] .
Two of the three studies that assessed 6MWT provided sufficient information to pool results [19, 25] . These trials included 48 participants and demonstrated a statistically significant improvement of 87.84 m (39.60-136.09, P ¼ 0.0004, Figure 2B ) in favour of IDC. There was no evidence of statistical heterogeneity (I 2 ¼ 0%). The study excluded from synthesis also suggested a significant improvement in the IDC group (P < 0.05) [31] . Only one included study assessed ISWT [20] whereby a statistically significant 15% (P ¼ 0.03) improvement in distance walked was observed in the IDC group.
Quality of life. The Medical Outcomes Short Form 36 (SF-36) tool reports QoL as physical (PCS) and mental component scores (MCS) [34] . Two studies with a total of 52 participants reported the effect of IDC on PCS and MCS. Due to baseline imbalances between groups for one of the two included studies [25] , both PCS and MCS summary for the SF-36 were assessed as change from baseline scores. Of these studies, only one reported mean change and SD [24] . For the remaining other study [25] , we used a conservative estimated correlation coefficient value of 0.5 [35] to calculate SD of change scores. No statistical differences were observed between IDC and usual care for the PCS (1.97, À8.27 to 12.22, P ¼ 0.7, Figure 3A ) or MCS scores (3.37, À7.94 to 14.68, P ¼ 0.6, Figure 3B ) of the SF-36. Statistical heterogeneity was not evident for the MCS (I 2 ¼ 0%), and was neglible for the PCS (I 2 ¼ 18%).
Cardiac outcomes. Five studies reported cardiovascular outcomes, of these three measured resting systolic blood pressure (SBP) and diastolic blood pressure (DBP) [17, 20, 25] , and two measured pulse wave velocity [17, 25] . Three studies recorded findings from echocardiogram [20, 29, 30] . Intradialytic aerobic cycling exercise: systematic review
One trial was excluded from meta-analysis for SBP due to a large baseline difference of 21.4 mmHg between the usual care and IDC groups [20] . This study did not report any significant effect on BP results. Synthesized data from the remaining two trials [17, 25] including 50 participants revealed a nonsignificant reduction in SBP of À2.28 mmHg with IDC (À14.46 to 9.90, P ¼ 0.7, Figure 4A ). Synthesized data from three trials including 67 participants demonstrated a non-significant increase of 2.25 mmHg in DBP with IDC (À3.01 to 7.50, P ¼ 0.4, Figure 4B ). There was no evidence of statistical heterogeneity for the SBP (I 2 ¼ 0%) and negligible heterogeneity for the DBP (I 2 ¼ 2%). Synthesized data from two trials measuring pulse wave velocity [17, 25] including 50 participants demonstrated a nonsignificant improvement of À0.57 m/s (À1.55 to 0.41, P ¼ 0.4, Figure 4C ) in the IDC group. There was no evidence of statistical heterogeneity (I 2 ¼ 0%). Of the three trials reporting echocardiography measures, two trials including 37 participants provided
2 in one study [20] and 13.9 g/m 2 in the other [29] , respectively. Neither reported any significant difference in LVMI following IDC.
Two studies including 62 patients measured left ventricular ejection fraction (LVEF). These were not included in a metaanalysis due to inadequate reporting of group size in one study [30] . This study saw a significant improvement in LVEF in the IDC group (P ¼ 0.004) [30] whilst the other reported no significant change [29] .
Physical function. Three studies reported physical function outcomes. The clinical diversity in outcome measures prevented pooling of results, but inspection of individual studies revealed limited impact of IDC across a range of measures. A single study of 29 participants revealed no statistically significant change in TUAG scores (À0.3 s, À1.39 to 0.77, P ¼ 0.9) between IDC and usual care [25] . Similarly, a single trial of 22 participants that reported a number of function measures observed non-statistically significant improvements in STS5 (À0.57 s, À1.85 to 0.71, P ¼ 0.4), STS30 (0.59 stands, À2.76 to 3.94, P ¼ 0.7), STS60 (0.50 stands, À5.67 to 6.67, P ¼ 0.9), normal gait speed (0.43 s, À0.67 to 1.53, P ¼ 0.5) and fast gait speed (0.08 s, À0.41 to 0.57, P ¼ 0.8) [24] . A baseline difference of 31.98 s between the IDC and control group was noted for the NSRI walk test, but analysis of mean change scores revealed a statisitically significant improvement in the NSRI walk test (À10.2 s, À17.6 to À2.8, P ¼ 0.007) following IDC [24] . Finally, a single trial of 21 participants reported a significant improvement in the number of steps completed in 6 min in the IDC group compared with usual care [32] ; however, a clinically relevant baseline imbalance of 15 steps between groups may have influenced these results.
D I S C U S S I O N

Main findings
The results of this systematic review and meta-analysis suggest that IDC can lead to statistically and clinically significantly improvements in exercise capacity measured via field testing, but current evidence demonstrates no statistically significant effect upon VO 2 peak, QoL, BP or arterial stiffness. Due to issues with trial reporting and substantial baseline imbalances in outcome measures between intervention groups and inconsistency in selection of outcome measures across studies, it was not possible to synthesize the effect of IDC on cardiac or physical function. The quality of the included evidence was considered to be at high risk of bias. Based upon this review, there is currently insufficient evidence to support the use of IDC in clinical practice to improve exercise capacity, QoL, cardiac or physical function.
Comparison with previous reviews
Our review, which focussed specifically upon intradialytic aerobic exercise, delivered using a static cycle ergometer, stands predominantly in contrast to previous publications. These reviews have shown significant improvements in exercise capacity [12, 13] physical QoL [12] and BP [13] . These differences may be explained by the inclusion of additional evidence in our data synthesis, the decision of previous reviews to include intradialytic exercise programmes consisting of a range of types of exercises within their meta-analyses or because they included interventions that were not exclusively aerobic training [36, 37] or delivered to HD patients [38] within their subgroup analyses [13] .
Implications for practice
Current evidence suggests patients, on average, observe a clinically important improvement of 87 m in the 6MWT after a programme of IDC, although the strength of this conclusion is limited by the high risk of bias within the two included studies [39] . Theoretically, an improvement in field tests of exercise capacity might reasonably be expected to be reflected in improvement in VO 2 peak, given that aerobic capacity contributes towards overall exercise capacity. The contrasting results seen in these two outcomes may be due to the inclusion of greater numbers of different trials within the meta-analysis for VO 2 peak in comparison with that for the 6MWT, other factors known to influence field test performance [5] and the use of different protocols to measure exercise capacity, which can influence the measurement of VO 2 peak, and its sensitivity to change following a programme of exercise [40] . The high prevalence of autonomic dysfunction in many HD patients may also be another reason for the discrepancy between the results of the two outcomes [41] . Autonomic dysfunction can lead to cardiac unresponsiveness, which is in turn associated with poor physical performance. Whilst speculative, it is possible that this may play a more important role during a higher intensity exercise test and therefore, patients may achieve greater improvements in field tests such as the 6MWT, when compared with VO 2 peak. Although, reduced exercise capacity and sedentary behaviour are powerful predictors of mortality in ESRD [4, 42, 43] , these results should not be extrapolated, as a causal link between increased exercise capacity through exercise training and decreased mortality has yet to be established. IDC also appeared to have little influence upon cardiovascular outcomes within the current review, although this may reflect a lack of high-quality RCTs rather than evidence of ineffectiveness.
Previous reviews have reported no significant adverse events [9, 12, 13] due to exercise training, citing these as evidence of safety. In the current review, eight trials failed to report information on adverse events and those which did only provided limited information. Therefore, it is difficult to make a clear judgement about the safety of IDC. A recent study of IDC noted a significant drop in BP 1 h post-exercise, with no reported adverse events [44] . Given the association between asymptomatic intradialytic hypotension and adverse outcomes [45, 46] , further research is needed to confirm that IDC is not associated with subclinical adverse events, or to provide clinicians with information about groups of patients for whom intradialytic exercise is not appropriate.
Exercise is beneficial across a spectrum of chronic diseases [47] and current Kidney Disease Outcomes Quality Initiative Adhere to CONSORT guidance for the reporting of non-pharmacologic trials [53] ; Use TIDieR checklist for intervention reporting [54] .
Four studies reported adherence levels and three summarized amount of exercise data. Five studies did not provide any information regarding the type of IDC training used. Poor reporting of study design and trial procedures All studies were rated as high risk of bias, primarily due to lack of sufficient reporting.
Adhere to CONSORT guidance for the reporting of NPTs [55] . Nine trials provided insufficient details and allocation concealment. Poor reporting of testing procedures in relation to field testing and patient reported outcomes Two studies provided no information on the procedures used during field tests.
Report:
Timing of testing in relation to HD treatment; Of those reporting, use of a familiarization test was not reported in one study, and another did not report if tests were conducted on non-HD or HD days or were standardized for follow-up. Adhere to CONSORT reporting guidance, including specific guidance for reporting harms [56] ; Use of standardized and validated measurement instruments for adverse events, where possible. Reporting bias in relation to study results Selective outcome reporting in five of the studies due to incomplete reporting of outcomes or time points, reporting of only statistically significant outcomes. Only one study had published a protocol paper.
Registration of trials; Publication of protocol paper; Presentation of all data in numerical form, not solely figures; Adherence to CONSORT for NPT [53] ; Raw data freely available in repository.
Reduction of bias within trials Attrition bias
Of the 10 studies providing information about attrition, a mean of 23% (range 6-56%) of participants were lost to follow-up in the IDC group, and 14%, (range 0-56%) in usual care. Only one study reported the use of an intention to treat analysis for their primary outcome measure.
Reduce dropout: Minimize number of visits or integrate into usual care; Allow step-wise withdrawal if unavoidable; Engage a patient involvement group to provide patient perspective on trial procedures; Judicious selection of outcome measures; Feasibility studies prior to full-scale trial. Undertake an intention to treat analysis. Explicitly state the methods used to address missing data. Small sample sizes and underpowered studies Only three studies based their sample sizes on an a priori power calculation for their primary outcome. One was unable to recruit the required number of patients.
A priori power calculation for primary outcome measure for RCTs or report as a feasibility or pilot study, with appropriate outcomes, limitations and conclusions; Trials of exercise and rehabilitation can be challenging to deliver and the numbers of patients required to adequately power outcomes may be large depending on the chosen primary outcome measure.
collaborative, multi-center working to increase sample sizes.
Lack of blinding of participants and intervention providers
Three studies reported that they were unable to blind participants and personnel, others do not report blinding.
Report blinding explicitly including methods and the fidelity; Where blinding not possible, strategies to reduce bias should be reported; Lack of blinding of outcome assessors Blinding of outcome assessment was reported incompletely in only five studies, all of which were high risk due to explicit lack of blinding or researchers assisting participants to complete QoL questionnaires.
Aim to use blinded outcome assessors where possible; Report blinding explicitly including methods and the fidelity; Where blinding not possible, strategies to reduce bias should be reported.
Baseline imbalances
Five studies demonstrated large, potentially clinically significant differences between control and IDC groups for baseline LVMI, SBP, the SF-36 and some measures of physical function, although all authors state that these differences were not statistically significant.
Adequate sample sizes and randomization procedures; Identification of important baseline differences a priori; Discuss characteristics of important differences in results; Do not use significance testing to determine if baseline imbalances exist.
Continued guidelines recommend patients with chronic kidney disease to undertake 'an exercise program compatible with cardiovascular health and tolerance, aiming for at least 30 minutes 5 times per week' [48] . Expert statements provide more specific guidance [49, 50] and systematic reviews have extolled the benefits of exercise for HD patients [7-10, 12, 13] . These have all led to increasing calls for exercise, particularly intradialytic, to become a routine part of the care of HD patients [13, 51, 52] . The results of this review suggest, however, that the specific effects of IDC are currently unknown, primarily due to the methodological shortcomings of existing trials. Further to this, high-quality, well-reported, RCTs are required. Two such trials, PEDAL (NCT02222402) and CYCLE-HD (ISRCTN11299707) [58] , will imminently provide evidence of the ability of intradialytic exercise to influence cardiac function and QoL, which may further inform best practice. Table 2 outlines several implications for future research that have been highlighted by this review. Unclear reporting was a feature of most IDC trials, and the primary reason for high risk of bias. Evidence presented by unclear trials rarely leads to change in practice or advances in research, because clinicians and policymakers lack confidence in the validity of findings and interventions can rarely be replicated [53, 55] . Whilst we acknowledge that several IDC trials included within this review precede the publication of this guidance, future trials should adhere to both CONsolidated Standards of Reporting Trials (CONSORT) guidance for the reporting of non-pharmacologic trials and use the Template for Intervention Description and Replication (TIDieR) checklist for intervention reporting [53, 54] .
Implications for research
Most trials were small, and not powered to detect a true effect [59] . Studies reporting echocardiography and harms are particularly vulnerable to lack of statistical power [60] [61] [62] [63] . Lack of blinding, which can influence the participant, intervention provider and outcome assessor behaviour, leading to over-estimation of effect [59, 64, 65] , particularly within nonpharmacologic trials [66] and 'per protocol' analysis, which may bias the estimated effects, were also common [64, 67, 68] . Future trials should endeavour to adequately power studies, and aim to report blinding methods and fidelity explicitly [59] .
Inconsistent use of a wide range of outcome measures limited meta-analyses, highlighting the need for a core outcome set to be measured and reported in all trials, alongside outcomes relevant to the individual study. Standardized Outcomes in Nephrology (SONG) aims to develop a core set of validated outcomes that reflect the main concerns of key stakeholders, including patients [57] . Thirty-four priority areas have been identified, $21 of which may potentially be influenced by exercise interventions. Once standardized outcome measures have been established, better synthesis of studies will be possible, allowing comparisons of different interventions across outcomes [57, 69] .
Limitations
Due to inadequate reporting, two potentially relevant studies were excluded [38, 70] . Additionally, six included trials presented outcome data incompletely [16, 20, 27, [31] [32] [33] . Attempts to obtain these data were unsuccessful. The inclusion of these may have provided additional information for meta-analyses, potentially providing larger sample sizes and greater statistical power. The limited number of eligible studies meant it was not possible to assess publication bias or conduct subgroup analyses. Further analyses of specific characteristics of the IDC intervention (e.g. duration of programme, adherence and intensity of exercise) would have provided information on potential reasons for differences in outcomes. Despite the lack of funnel plots, risk of publication bias is minimal, as many included studies reported statistically non-significant results. Unpublished studies with statistically non-significant results may exist, but their addition is not likely to change our conclusions.
C O N C L U S I O N S
The renal community remains in a position of equipoise regarding IDC, because of a lack of high-quality RCT data. This review highlights the need for adequately powered trials that adhere to published reporting guidance and, as far as possible, take steps to remedy the methodological limitations of trials that have gone before. MCID, minimum clinically important difference; SONG-HD, Standardized Outcomes in Nephrology-Haemodialysis; NPTs, non-pharmacologic trials.
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